Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation

This study reports a case of hepatoblastoma with onset at 30-weeks' gestation and rapid growth rate. The postnatal enhanced CT confirmed an intrahepatic mass with a size of 8.5 cm × 6.6 cm and a clear boundary accompanied by uneven enhancement, displacement, and narrow lumen of the hepatic vein...

Full description

Bibliographic Details
Main Authors: Zheng Yan, Wei Bai, Li Li, Shuo Li, Ying Hua, Xiao-xiao Zhang, Xin-lin Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.905089/full
_version_ 1818236108849283072
author Zheng Yan
Wei Bai
Li Li
Shuo Li
Ying Hua
Xiao-xiao Zhang
Xin-lin Hou
author_facet Zheng Yan
Wei Bai
Li Li
Shuo Li
Ying Hua
Xiao-xiao Zhang
Xin-lin Hou
author_sort Zheng Yan
collection DOAJ
description This study reports a case of hepatoblastoma with onset at 30-weeks' gestation and rapid growth rate. The postnatal enhanced CT confirmed an intrahepatic mass with a size of 8.5 cm × 6.6 cm and a clear boundary accompanied by uneven enhancement, displacement, and narrow lumen of the hepatic vein due to compression. The alpha-fetoprotein (AFP) at birth was 1,002,632 ng/ml (normal level 48,406 [±34,718] ng/ml). A diagnosis of congenital hepatoblastoma was established based on the imaging and laboratory outcomes. The infant received chemotherapy of Cisplatin-5 fluorouracil-Vincristine (C5V) on the fourth day after birth. After four courses of C5V, a complete tumor resection was performed, and the postoperative pathology was consistent with mixed epithelial and mesenchymal hepatoblastoma. Four more courses of C5V and one course of C5VD (C5V plus doxorubicin) followed the surgery. Infectious diarrhea and acute kidney injury (stage I) occurred during chemotherapy, which recovered after anti-infection and symptomatic treatment. The patient is currently 2 years old and still in complete remission. In this case, the onset of hepatoblastoma was early, and the tumor grew rapidly, resulting in an obvious compression effect. Chemotherapy was started early after birth, and the curative effect was satisfactory, suggesting that the hepatoblastoma based on clinical diagnosis with rapid tumor progression and severe dysfunction of surrounding organs caused by compression should undergo chemotherapy as soon as possible if a pathological diagnosis cannot be obtained temporarily, which also plays an important role in improving the complete resection rate of intraoperative tumor and reducing the recurrence rate of postoperative tumor.
first_indexed 2024-12-12T12:04:38Z
format Article
id doaj.art-17c597776fd64d06907af56f52a6e6b1
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-12T12:04:38Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-17c597776fd64d06907af56f52a6e6b12022-12-22T00:25:01ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-07-011010.3389/fped.2022.905089905089Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' GestationZheng Yan0Wei Bai1Li Li2Shuo Li3Ying Hua4Xiao-xiao Zhang5Xin-lin Hou6Department of Pediatrics, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, Peking University First Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, Peking University First Hospital, Beijing, ChinaThis study reports a case of hepatoblastoma with onset at 30-weeks' gestation and rapid growth rate. The postnatal enhanced CT confirmed an intrahepatic mass with a size of 8.5 cm × 6.6 cm and a clear boundary accompanied by uneven enhancement, displacement, and narrow lumen of the hepatic vein due to compression. The alpha-fetoprotein (AFP) at birth was 1,002,632 ng/ml (normal level 48,406 [±34,718] ng/ml). A diagnosis of congenital hepatoblastoma was established based on the imaging and laboratory outcomes. The infant received chemotherapy of Cisplatin-5 fluorouracil-Vincristine (C5V) on the fourth day after birth. After four courses of C5V, a complete tumor resection was performed, and the postoperative pathology was consistent with mixed epithelial and mesenchymal hepatoblastoma. Four more courses of C5V and one course of C5VD (C5V plus doxorubicin) followed the surgery. Infectious diarrhea and acute kidney injury (stage I) occurred during chemotherapy, which recovered after anti-infection and symptomatic treatment. The patient is currently 2 years old and still in complete remission. In this case, the onset of hepatoblastoma was early, and the tumor grew rapidly, resulting in an obvious compression effect. Chemotherapy was started early after birth, and the curative effect was satisfactory, suggesting that the hepatoblastoma based on clinical diagnosis with rapid tumor progression and severe dysfunction of surrounding organs caused by compression should undergo chemotherapy as soon as possible if a pathological diagnosis cannot be obtained temporarily, which also plays an important role in improving the complete resection rate of intraoperative tumor and reducing the recurrence rate of postoperative tumor.https://www.frontiersin.org/articles/10.3389/fped.2022.905089/fullalpha-fetoprotein (AFP)chemotherapycongenital hepatoblastomarecurrencesurgery
spellingShingle Zheng Yan
Wei Bai
Li Li
Shuo Li
Ying Hua
Xiao-xiao Zhang
Xin-lin Hou
Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
Frontiers in Pediatrics
alpha-fetoprotein (AFP)
chemotherapy
congenital hepatoblastoma
recurrence
surgery
title Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
title_full Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
title_fullStr Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
title_full_unstemmed Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
title_short Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
title_sort case report of congenital hepatoblastoma with the onset at 30 weeks gestation
topic alpha-fetoprotein (AFP)
chemotherapy
congenital hepatoblastoma
recurrence
surgery
url https://www.frontiersin.org/articles/10.3389/fped.2022.905089/full
work_keys_str_mv AT zhengyan casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT weibai casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT lili casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT shuoli casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT yinghua casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT xiaoxiaozhang casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation
AT xinlinhou casereportofcongenitalhepatoblastomawiththeonsetat30weeksgestation